BAALC (Brain and Acute Leukemia, Cytoplasmic) is a neuroectoderm-derived gene located at chromosome 8.3 that plays critical roles in cellular proliferation, survival, and potentially cytoskeletal organization 1. The protein localizes to the cytoplasm and may function within cytoskeletal networks, with specific expression in neuroectoderm-derived tissues under normal conditions 1. BAALC demonstrates oncogenic properties by promoting cell proliferation and inhibiting apoptosis in leukemia cells, as demonstrated by shRNA knockdown studies showing decreased proliferation and enhanced apoptosis in AML cell lines 2. In breast cancer, BAALC overexpression increases proliferation, anchorage-independent growth, invasion, and migration through FAK-dependent signaling and MMP-9 activity 3. Clinically, BAALC serves as a significant prognostic biomarker across multiple malignancies. In acute myeloid leukemia, high BAALC expression is associated with poor prognosis, shorter overall survival, and adverse outcomes, particularly in normal karyotype AML 145. BAALC expression remains stable between diagnosis and relapse, making it valuable for minimal residual disease monitoring and risk stratification 6. The gene's prognostic value extends to myelodysplastic syndromes and breast cancer, where overexpression correlates with reduced survival and increased metastatic potential 73.